Q2043 Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion

Short descriptor: Sipuleucel-t auto cd54+

✓ Active HCPCS Level II 2026
Open Q2043 in the app →

Look up Q2043 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q2043 is the HCPCS Level II code for Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Medical care
Effective Date
2011-07-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q2043 with the canonical source and edition:

Q2043 — Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q2043

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q2043

Related Codes in Section Q

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial